Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer-Reference-Cited by-同舟云学术

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer

Published:2001-08 Issue:8 Volume:12 Page:1065-1071
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gianni L.,Dombernowsky P.,Sledge G.,Martin M.,Amadori D.,Arbuck S.G.,Ravdin P.,Brown M.,Messina M.,Tuck D.,Weil C.,Winograd B.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/12/8/1067/19479616/12-8-1067.pdf

Reference23 articles.

1. A phase I – II study of intensive dose Adriamycin for advanced breast cancer;Jones;J Clin Oncol,1987

2. Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyle colony-stimulating factor in patients with metastatic breast cancer;Fisherman;J Clin Oncol,1996

3. Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer;Holmes;J Clin Oncol,1996

4. Phase I study of TAXOL and doxorubicin with G-CSF in patients without prior chemotherapy for metastatic breast cancer;Holmes;Proc Am Soc Clin Oncol,1992

5. Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: High antitumor efficacy and cardiac effect in a dose-finding and sequence-finding study;Gianni;J Clin Oncol,1995

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac Complications;Holland‐Frei Cancer Medicine;2022-10-21

2. Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab;Frontiers in Cardiovascular Medicine;2022-09-23

3. Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the C ardio‐ O ncology S tudy G roup of the H eart F ailure A ssociation of the E uropean S ociety of C ardiology in collaboration with the I nternational C ardio‐ O ncology S ociety;European Journal of Heart Failure;2020-08-06

4. Risk factors for chemotherapy-related cardiac toxicity;Current Opinion in Cardiology;2019-05

5. Multifunctional Nanosystem for Targeted and Controlled Delivery of Multiple Chemotherapeutic Agents for the Treatment of Drug-Resistant Breast Cancer;ACS Omega;2018-08-15